|Study Type:||Phase I|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase I dose-escalation clinical trial to evaluate the safety and immunogenicity of the EP HIV-1090 DNA vaccine in healthy, HIV-1-uninfected adult participants
HVTN 048 is a Phase I clinical trial to evaluate the safety and immunogenicity of EP HIV-1090 DNA.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.